10q10k10q10k.net
ORTHOPEDIATRICS CORP

ORTHOPEDIATRICS CORPKIDSEarnings & Financial Report

Nasdaq

OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana.

NextMar 5, 2026

KIDS Q3 2025 Key Financial Metrics

Revenue

$61.3M

Gross Profit

$45.3M

Operating Profit

$-9.4M

Net Profit

$-11.8M

Gross Margin

73.9%

Operating Margin

-15.4%

Net Margin

-19.2%

YoY Growth

12.2%

EPS

$-0.50

Financial Flow

ORTHOPEDIATRICS CORP Q3 2025 Financial Summary

ORTHOPEDIATRICS CORP reported revenue of $61.3M for Q3 2025, with a net profit of $-11.8M (-19.2% margin). Cost of goods sold was $16.0M, operating expenses totaled $54.7M.

Key Financial Metrics

Total Revenue$61.3M
Net Profit$-11.8M
Gross Margin73.9%
Operating Margin-15.4%
Report PeriodQ3 2025

ORTHOPEDIATRICS CORP Annual Revenue by Year

ORTHOPEDIATRICS CORP annual revenue history includes year-by-year totals (for example, 2024 revenue was $204.7M).

YearAnnual Revenue
2024$204.7M
2023$148.7M
2022$122.3M

Income Statement

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Revenue$37.6M$44.7M$52.8M$54.6M$52.7M$52.4M$61.1M$61.3M
YoY Growth21.4%41.5%33.5%36.5%40.0%17.3%15.7%12.2%

Balance Sheet

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Assets$438.7M$437.2M$430.8M$489.3M$473.2M$470.3M$503.6M$493.5M
Liabilities$61.7M$66.6M$59.5M$118.4M$118.6M$123.1M$148.1M$144.2M
Equity$377.0M$370.6M$371.3M$370.9M$354.6M$347.1M$355.5M$349.3M

Cash Flow

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Operating CF$-7.5M$-6.7M$-6.1M$-10.3M$-4.0M$-4.2M$-10.5M$-581000